You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced or Metastatic Solid Tumor Malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Or Metastatic Solid Tumor Malignancies Trial (SHR-A2102)

Not yet recruiting
  • Advanced Or Metastatic Solid Tumor Malignancies
  • (no location specified)
Feb 9, 2023

Metastatic Solid Tumor, Advanced Solid Tumor Trial (XT-0528)

Not yet recruiting
  • Metastatic Solid Tumor
  • Advanced Solid Tumor
  • (no location specified)
Jul 22, 2022

NSCLC, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Duarte (JANX008)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 29, 2023

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

Recruiting
  • Cancer
  • +4 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 24, 2023

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Trial in Chuo-ku (ASP1948)

Completed
  • Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
  • Chuo-ku, Tokyo, Japan
    Site JP810001
Jan 17, 2023

Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Kansas City, Kansas
  • +2 more
Mar 16, 2023

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Advanced or Metastatic Solid Tumor Malignancies Trial in United States (NP-G2-044 Monotherapy, Anti-PD-(L)1 Therapy, NP-G2-044

Recruiting
  • Advanced or Metastatic Solid Tumor Malignancies
  • NP-G2-044 Monotherapy
  • +2 more
  • Scottsdale, Arizona
  • +14 more
Jan 5, 2023

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • TransCon IL-2 β/γ
  • +4 more
  • Boston, Massachusetts
  • +7 more
Nov 16, 2022

Adult Solid Tumor Trial (LTC004)

Not yet recruiting
  • Adult Solid Tumor
  • LTC004
  • (no location specified)
Dec 18, 2022

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym021, Sym022, Sym023)

Completed
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 25, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 5, 2022

Locally Advanced Solid Tumor, Metastatic Solid Tumor, Hematologic Malignancies Trial (CN202)

Not yet recruiting
  • Locally Advanced Solid Tumor
  • +2 more
  • (no location specified)
Aug 25, 2021

Advanced/Metastatic Solid Tumor Trial in United States (KZR-261)

Recruiting
  • Advanced/Metastatic Solid Tumor
  • Los Angeles, California
  • +6 more
Aug 10, 2022

Solid Tumor Trial in Beijing (SHR-1916)

Recruiting
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 27, 2022

Advanced Solid Tumor, Metastatic Solid Tumor, Urothelial Carcinoma Trial in United States (Lurbinectedin)

Recruiting
  • Advanced Solid Tumor
  • +4 more
  • Stanford, California
  • +15 more
Dec 21, 2022

Advanced Solid Tumor, Metastatic Solid Tumor Trial (MPT0B640)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 25, 2021

Melanoma, NSCLC, Colorectal Cancer Trial in United States (LYL845)

Recruiting
  • Melanoma
  • +2 more
  • LYL845
  • Columbus, Ohio
  • +3 more
Dec 19, 2022

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • Duarte, California
  • +12 more
Sep 21, 2022

Cancer, Tumor, Solid, Nonsmall Cell Lung Cancer Trial in United States (HMBD-002, Pembrolizumab)

Recruiting
  • Cancer
  • +6 more
  • Duarte, California
  • +6 more
Dec 26, 2022

Metastatic Cancer, Solid Tumor Trial in Canada, United States (Sym021, Sym024)

Recruiting
  • Metastatic Cancer
  • Solid Tumor
  • Grand Rapids, Michigan
  • +3 more
Dec 16, 2021

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022